CreditReports.dk
HomeScreen companies

Nest Egg ApS Financials, key figures and credit report

CVR number: 33876793 Established 2011 Industry: 70 Activities of head offices and management consultancy
Company contact details
Hejrevej 39, 2400 København NV info@macurepharma.com tel: 70204007
Gross profit 174 507.7 kDKK FY 2025 +15% vs 2024
EBIT 150 054.2 kDKK FY 2025 +12.3% vs 2024
Net debt -38 599.0 kDKK FY 2025 -24.5% vs 2024
Quick ratio 1.8 FY 2025 +0.3 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit77 115.84158 823.38123 986.34151 798.52174 507.74
Employee benefit expenses-30 376.54-25 599.95-15 192.89-17 554.12-23 046.40
Total depreciation- 297.54- 285.09-1 452.38- 637.77-1 407.09
EBIT46 441.76132 938.34107 341.06133 606.62150 054.24
Other financial income112.05120.682 383.364 322.324 251.47
Other financial expenses- 224.06-1 104.79-2 422.77-14 573.12-10 535.12
Pre-tax profit46 329.75131 954.23107 301.66123 355.83143 770.59
Income taxes-10 152.35-28 921.40-23 568.41-27 648.38-32 199.98
Net earnings36 177.41103 032.8383 733.2595 707.45111 570.61

Assets (kDKK)

2021
2022
2023
2024
2025
Development expenditure2 017.21
Intangible rights3 231.694 238.096 483.5610 595.8615 980.49
Intangible assets total3 231.694 238.096 483.5610 595.8617 997.70
Buildings683.904 337.27
Tangible assets total683.904 337.27
Investments total146.67167.99169.551 184.141 079.60
Long term receivables total
Raw materials and consumables1 008.761 549.63
Finished products/goods25 911.5528 969.0028 035.7632 950.3645 046.98
Advance payments214.72238.1495.00
Inventories total25 911.5528 969.0029 259.2334 738.1445 141.98
Current trade debtors53 364.3191 143.4952 935.4457 410.9257 215.40
Prepayments and accrued income408.131 027.491 930.692 304.50
Current other receivables13 944.7332 338.6767 690.8197 719.7426 591.15
Current deferred tax assets1 362.51446.02214.675 140.673 472.89
Short term receivables total68 671.56124 336.31121 868.40162 202.0389 583.94
Cash and bank deposits53 321.0049 079.9782 121.0931 310.4238 820.03
Cash and cash equivalents53 321.0049 079.9782 121.0931 310.4238 820.03
Balance sheet total (assets)151 282.47206 791.37239 901.83240 714.49196 960.52

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital80.0080.0080.0080.0080.00
Shares repurchased37 800.0093 000.0083 500.0097 052.00116 500.00
Other reserves26.86- 382.27- 158.88- 581.46-1 492.86
Retained earnings-28 586.29-85 408.88-65 876.05-79 194.80-99 987.34
Profit of the financial year36 177.41103 032.8383 733.2595 707.45111 570.61
Shareholders equity total45 497.98110 321.68101 278.32113 063.19126 670.40
Provisions70.42815.84
Non-current liabilities total
Current loans from credit institutions96.93169.6786.28
Advances received464.7863.30120.755.76
Current trade creditors57 284.3141 993.21109 373.94119 237.4423 323.90
Current owed to participating23 310.372 372.1191.48139.88134.77
Short-term deferred tax liabilities340.5919 545.4817 282.031 828.111 628.15
Other non-interest bearing current liabilities24 849.2132 094.1111 715.826 085.0444 295.41
Current liabilities total105 784.4996 469.69138 623.51127 580.8869 474.27
Balance sheet total (liabilities)151 282.47206 791.37239 901.83240 714.49196 960.52
Page generated